Central Pontine Myelinolysis Market Research Report 2017 Analysis and Forecast To 2023

Central Pontine Myelinolysis Market Accretes Dramatically With A Whooping CAGR of ~ 5.5% by 2023; Confirms MRFR
DECEMBER 4TH, 2017 MARKET RESEARCH FUTURE RELEASES

Facebook Twitter Google+ LinkedIn
Acknowledging its growing popularity and the market growth, Market Research Future, recently published a study report – The Global Central Pontine Myelinolysis Market. Which indicates that the Market is booming and estimated to gain further prominence over the forecast period. Further MRFR asserts that the Market will demonstrate a massive growth by 2023, phenomenally superseding its previous growth records in terms of value with a whooping CAGR during the anticipated period considering all these factors The World Central Pontine Myelinolysis Market research report is growing continuously and expected to grow at a to reach US$ 2.2 billion by 2023, and the market is projected to grow at a CAGR of ~ 5.5 % during the forecast period 2017-2023.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4580 .

Market Research Future published new report, titled “Central Pontine Myelinolysis Market -Research Report: Global Forecast till 2023”.

Central Pontine Myelinolysis Market Information: By Diagnosis (Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), Electroencephalography, Others) By Treatment (Vitamin Supplementation, Electrolyte Mainainence, others)) By End Users – Global Forecast till 2023

Market Highlights:
Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of nerve cells. CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms. These neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures etc. Serious progressive neurological symptoms are, progressive development of spastic tetraparesis, pseudobulbar palsy etc.

The diagnosis segment of central pontine myelinolysis especially the Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) is growing fast. MRI is the test of choice with its high specificity and correct diagnosis capabilities.

The market drivers for central pontine myelinolysis market are increasing risk factors and cases of liver disease, liver transplant, alcoholism, severe burns, malnutrition, anorexia, severe electrolyte disorders, AIDS, hyperemesis gravidarum, anorexia nervosa, hematopoietic stem cell transplantation, Wernicke encephalopathy etc. The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc.

Global Central pontine myelinolysis Fujifilm Holdings Corporation, GE Healthcare, Siemens Healthcare GmbH, Philips Healthcare (Koninklijke Philips N.V.), Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Hitachi Medical Corporation and others.

Some of Key Players:
Fujifilm Holdings Corporation
GE Healthcare
Siemens Healthcare GmbH
Philips Healthcare
Shimadzu Corporation
Toshiba Medical Systems Corporation
Carestream Health
Hitachi Medical Corporation and others.
Market Segments:

The global central pontine myelinolysis market has been segmented on the basis of diagnosis, treatment, and end users.

Based on diagnosis, the market has been segmented as magnetic resonance imaging (MRI), computerized tomography (CT), electroencephalography and others.

Based on treatment, the market has been segmented as vitamin supplementation, electrolyte mainainence and others.

Based on the end users, the market has been segmented as hospitals & clinics, academic and research and others.

GET FULL REPORT @ https://www.marketresearchfuture.com/reports/central-pontine-myelinolysis-market-4580 .

Regional Analysis:
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new drugs in the US drives the central pontine myelinolysis market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The large expenditure on the US healthcare accounting to 16% of GDP also cruises the sale of central pontine myelinolysis treatment.

Europe is the second largest market in the world due to high income and healthcare penetration. Europe is led by nations such as Germany and France. UK is expected to be the fastest growing market.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Central pontine myelinolysis Market” Research Report – Forecast till 2023.

Major Table of Contents:
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Market Dynamics
Chapter 4 Market Factor Analysis
Chapter 5 Global Central Pontine Myelinolysis Market, By Diagnosis
Chapter 6 Global Central Pontine Myelinolysis Market, By Treatment
Chapter 7 Global Central Pontine Myelinolysis Market, By End Users
Chapter 8 Global Central Pontine Myelinolysis Market, By Region
Chapter 9 Competitive Landscape
Chapter 10 Company Profile
Chapter 11 Conclusion
Chapter 12 Appendix

…CONTINUED

GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4580 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.